Evoke Pharma Inc Quarterly Operating Margin in % from Q4 2021 to Q3 2024

Taxonomy & unit
ratio: %
Description
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
Summary
Evoke Pharma Inc quarterly/annual Operating Margin history and growth rate from Q4 2021 to Q3 2024.
  • Evoke Pharma Inc Operating Margin for the quarter ending September 30, 2024 was -68.5 %, a 59.4% increase year-over-year.
  • Evoke Pharma Inc annual Operating Margin for 2023 was -143 %, a 53.8% increase from 2022.
  • Evoke Pharma Inc annual Operating Margin for 2022 was -310 %, a 38.4% increase from 2021.
  • Evoke Pharma Inc annual Operating Margin for 2021 was -504 %, a 99.1% increase from 2020.
Operating Margin, Quarterly (%)
Operating Margin, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2024 -68.5 +100 +59.4% Jul 1, 2024 Sep 30, 2024
Q2 2024 -82.6 +129 +61% Apr 1, 2024 Jun 30, 2024
Q1 2024 -111 +161 +59.2% Jan 1, 2024 Mar 31, 2024
Q4 2023 -143 +167 +53.8% Oct 1, 2023 Dec 31, 2023
Q3 2023 -169 +199 +54.2% Jul 1, 2023 Sep 30, 2023
Q2 2023 -212 +136 +39.1% Apr 1, 2023 Jun 30, 2023
Q1 2023 -272 +119 +30.5% Jan 1, 2023 Mar 31, 2023
Q4 2022 -310 +193 +38.4% Oct 1, 2022 Dec 31, 2022
Q3 2022 -368 Jul 1, 2022 Sep 30, 2022
Q2 2022 -348 Apr 1, 2022 Jun 30, 2022
Q1 2022 -391 Jan 1, 2022 Mar 31, 2022
Q4 2021 -504 Oct 1, 2021 Dec 31, 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.